Mr Rémi Droller

KANDO id: 1308

Bio

Remi Droller joined AGF Private Equity in 2003 to manage investments in Life Sciences. He serves as Board member of Integragen, Zealand Pharma and Novagali Pharma and is also responsible for the investment in Neurotech. Before joining AGF Private Equity, Remi Droller spent three years working for CDC Ixis Innovation (renamed CDC Entreprises Innovation), where he was in charge of identifying investment opportunities and conducting detailed analyses. Holds a postgraduate degree in Molecular Biology (Paris VI University) and a master's degree in management of science and innovation from INA-PG/ESC, Reims.

Education